Recovery from the hepatic acute phase response in the severely burned and the effects of long-term growth hormone treatment.

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.

Treatment during convalescence has not been examined.

Who Took Part

PubMed indexes the participants as children, both men and women.

Subjects were followed for an additional year.

How the Study Was Run

The design is described as randomized and placebo-controlled.

Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

A placebo (an inactive look-alike) gave the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group a baseline to be compared against.

Levels of constitutive proteins and acute phase proteins were measured at discharge and 6, 9, 12, 18, and 24 months.

Data are expressed as mean +/- S.E.M.

What Was Measured

The subject headings attached to it are Acute-Phase Proteins, Acute-Phase Reaction, Burns, Human Growth Hormone, Liver, Prealbumin and Recombinant Proteins.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2004 (Burns : journal of the International Society for Burn Injuries), a journal based in Netherlands.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.